Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.850
+0.140 (8.19%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of $147.77 million as of October 29, 2024. Its market cap has decreased by -20.72% in one year.

Market Cap
147.77M
Enterprise Value
86.96M
1-Year Change
-20.72%
Ranking
Category
Stock Price
$1.85

Market Cap Chart

Since October 18, 2019, Innate Pharma's market cap has decreased from $458.70M to $147.77M, a decrease of -67.78%. That is a compound annual growth rate of -20.15%.

History

DateMarket Cap% Change
Oct 28, 2024138.50M-38.55%
Dec 29, 2023225.40M-24.36%
Dec 30, 2022298.00M-17.31%
Dec 31, 2021360.40M12.13%
Dec 31, 2020321.40M-33.19%
Dec 31, 2019481.10M4.88%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Tenaya Therapeutics 154.62M
Repare Therapeutics 152.38M
Vigil Neuroscience 151.45M
Compugen 149.53M
Eledon Pharmaceuticals 148.57M
Nuvectis Pharma 146.80M
Cardiol Therapeutics 146.42M
Cardiff Oncology 145.23M
Market Cap Rankings